Supplementary Figure 19 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

<p>Supplementary Figure S19 illustrates the serum inosine levels in multiple myeloma (MM) patients from the first cohort. This figure tracks the longitudinal changes in inosine levels at apheresis, 28 days post-CAR T-cell infusion, and 12 months post-infusion. It also presents inosine levels at apheresis stratified by therapy outcome and at 28 days post–CAR T-cell infusion stratified by therapy outcome.</p>

Authors

Publication Details

Published
2025-09-03
DOI
https://doi.org/10.1158/2643-3230.30040900
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary Figure 19 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

Iñaki Ortiz de Landazuri, Núria Amigó, Juan Luis Reguera, Elisa Rubio-García et al.
CAR-T cell therapy research
article

Supplementary Figure 19 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

Iñaki Ortiz de Landazuri, Núria Amigó, Juan Luis Reguera, Elisa Rubio-García, Álvaro Urbano-Ispizúa, Julio Delgado, Andrea Vergara, Roberto Martínez-Soler, Mariona Pascal, Luis Gerardo Rodríguez‐Lobato, María‐Victoria Mateos, Marta Español‐Rego, Nela Klein-González, Joaquín Martínez‐López, Neus Martínez-Micaelo, Carlos Fernández de Larrea, Maria Val-Casals, Mireia Uribe‐Herranz, Verónica González‐Calle, Valentín Ortiz‐Maldonado, Aina Oliver‐Caldés, Bruno Paiva, Valentín Cabañas, Europa Azucena González‐Navarro, Manel Juan, Beatriz Martín-Antonio, Lorena Pérez-Amill, Daniel Benítez‐Ribas, Paula Rodríguez‐Otero, Erik Z. Mihelic, Valeria Brunello
article en

Abstract

<p>Supplementary Figure S19 illustrates the serum inosine levels in multiple myeloma (MM) patients from the first cohort. This figure tracks the longitudinal changes in inosine levels at apheresis, 28 days post-CAR T-cell infusion, and 12 months post-infusion. It also presents inosine levels at apheresis stratified by therapy outcome and at 28 days post–CAR T-cell infusion stratified by therapy outcome.</p>

Openalex Percentile: Top 67%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.